Kevin Lalande Net Worth & Insider Trades

Kevin Lalande - Director, Lumos Pharma, Inc

As of May 9, 2022

What is Kevin Lalande's Net Worth?

The current estimated net worth of Lumos Pharma, Inc's Director, Kevin Lalande, is estimated to be about $18.12M . Kevin Lalande owns about 731,522 units of Lumos Pharma, Inc common stock. In the last 2 years at Lumos Pharma, Inc, Kevin Lalande has sold an estimated value of $0 worth.

What is Kevin Lalande's Past Insider Trading?

Kevin Lalande's largest purchase order was 84,254 units , worth over $775.66K on August 24, 2021. In total, Kevin Lalande has made about 10 transactions over 2 years of their time at Lumos Pharma, Inc. Kevin Lalande usually trades in August, with the busiest year in 2021. The most recent transaction was a purchase order of 10,000 units , worth over $112.12K on September 10, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kevin Lalande's' Mailing Address?

  • Mailing address is 201 West 5th Street Austin TX 78701 TX

Lumos Pharma, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Richard J. Hawkins* 2020 $516,380 $196,750 $759,063 $686,336 $63,500 $2,222,029
Richard J. Hawkins* 2019 $425,000 - $136,720 $178,500 - $740,220
John C. McKew* 2020 $436,300 $102,310 $365,475 $276,044 $35,641 $1,215,770
John C. McKew* 2019 $412,000 - - $144,200 - $556,200
Eugene P. Kennedy, M.D.** 2020 $459,638 $70,830 $253,021 $300,770 $62,040 $1,146,299
Eugene P. Kennedy, M.D.** 2019 $437,750 - $234,835 $192,610 $57,299 $922,494
Carl W. Langren 2020 $389,025 $70,830 $253,021 $269,926 $59,040 $1,041,842
Carl W. Langren 2019 $370,500 - $234,835 $163,020 $54,467 $822,822
Bradley J. Powers 2020 $380,000 $35,415 $140,567 $245,236 $51,842 $853,060
Bradley J. Powers 2019 $345,000 - $100,613 $151,800 $45,365 $642,778
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1126234/000112623421000050/lumo-def14ax2021.htm

What are Lumos Pharma, Inc's Past Insider Trades?

Lumos Pharma, Inc's most recent insider trade came on September 23, 2022 by Richard Hawkins who bought 2,422 units worth $21.4K . In the last year, insiders at Lumos Pharma, Inc have sold an estimated value of $172.82K and bought an estimated value of $3.15M worth of shares. Insider trading is most common in April, with the busiest year in 2021. The most active traders at the company are Kevin Lalande, Director,  John McKew, Chief Scientific Officer,  and Lori Lawley, Chief Financial Officer .

LUMOS PHARMA, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1